Effectiveness of Remdesivir, Lopinavir/Ritonavir, and Favipiravir for COVID-19 Treatment: A Systematic Review
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effectiveness of Remdesivir, Lopinavir/Ritonavir, and Favipiravir for COVID-19 Treatment: A Systematic Review
Authors
Keywords
-
Journal
International Journal of General Medicine
Volume Volume 14, Issue -, Pages 8557-8571
Publisher
Informa UK Limited
Online
2021-11-23
DOI
10.2147/ijgm.s332458
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Efficacy of favipiravir in COVID-19 treatment: a multi-center randomized study
- (2021) Hany M. Dabbous et al. ARCHIVES OF VIROLOGY
- Favipiravir in Therapy of Viral Infections
- (2021) Ryta Łagocka et al. Journal of Clinical Medicine
- Safety and effectiveness concerns of lopinavir/ritonavir in COVID-19 affected patients: a retrospective series
- (2021) Marc-Antoine Lepage et al. CLINICAL TOXICOLOGY
- Management of hospitalised adults with coronavirus disease-19 (COVID-19): A European Respiratory Society living guideline
- (2021) James D. Chalmers et al. EUROPEAN RESPIRATORY JOURNAL
- Safety and efficacy of Favipiravir in moderate to severe SARS-CoV-2 pneumonia
- (2021) Masoud Solaymani-Dodaran et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Nucleoside Analogs and Nucleoside Precursors as Drugs in the Fight against SARS-CoV-2 and Other Coronaviruses
- (2021) Nicola Borbone et al. MOLECULES
- Clinical efficacy and safety of remdesivir in patients with COVID-19: a systematic review and network meta-analysis of randomized controlled trials
- (2021) Chih-Cheng Lai et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Safety and Efficacy of Remdesivir for the Treatment of COVID-19: A Systematic Review and Meta-Analysis
- (2021) Mohammad Tasavon Gholamhoseini et al. JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES
- Safety and efficacy of favipiravir versus hydroxychloroquine in management of COVID-19: A randomised controlled trial
- (2021) Hany M. Dabbous et al. Scientific Reports
- The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
- (2021) Matthew J Page et al. BMJ-British Medical Journal
- Effect of Early Treatment With Hydroxychloroquine or Lopinavir and Ritonavir on Risk of Hospitalization Among Patients With COVID-19
- (2021) Gilmar Reis et al. JAMA Network Open
- Favipiravir for the treatment of patients with COVID-19: a systematic review and meta-analysis
- (2021) Toshie Manabe et al. BMC INFECTIOUS DISEASES
- Anti-Coronavirus Vaccines: Past Investigations on SARS-CoV-1 and MERS-CoV, the Approved Vaccines from BioNTech/Pfizer, Moderna, Oxford/AstraZeneca and others under Development Against SARS-CoV-2 Infection
- (2021) Michele Costanzo et al. CURRENT MEDICINAL CHEMISTRY
- Effectiveness of favipiravir in COVID-19: a live systematic review
- (2021) Batu Özlüşen et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Efficacy and safety of remdesivir in COVID-19 caused by SARS-CoV-2: a systematic review and meta-analysis
- (2021) Surjit Singh et al. BMJ Open
- Pharmacological Effects of Favipiravir on Coronavirus: An Update
- (2021) Prerna Tejaswi et al. Biomedical and Pharmacology Journal
- Connecting With Patients—The Missing Links
- (2020) Lisa Sanders et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Coronavirus Infections—More Than Just the Common Cold
- (2020) Catharine I. Paules et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Remdesivir in Treatment of COVID-19: A Systematic Benefit–Risk Assessment
- (2020) Miranda Davies et al. DRUG SAFETY
- COVID-19 illness in native and immunosuppressed states: A clinical–therapeutic staging proposal
- (2020) Hasan K. Siddiqi et al. JOURNAL OF HEART AND LUNG TRANSPLANTATION
- Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
- (2020) Yeming Wang et al. LANCET
- Remdesivir for 5 or 10 Days in Patients with Severe Covid-19
- (2020) Jason D. Goldman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Remdesivir for the Treatment of Covid-19 — Preliminary Report
- (2020) John H. Beigel et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19
- (2020) Bin Cao et al. NEW ENGLAND JOURNAL OF MEDICINE
- Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study
- (2020) Qingxian Cai et al. Engineering
- A prospect on the use of antiviral drugs to control local outbreaks of COVID-19
- (2020) Andrea Torneri et al. BMC Medicine
- Tocilizumab combined with favipiravir in the treatment of COVID-19: A multicenter trial in a small sample size
- (2020) Hong Zhao et al. BIOMEDICINE & PHARMACOTHERAPY
- Web tools to fight pandemics: the COVID-19 experience
- (2020) Daniele Mercatelli et al. BRIEFINGS IN BIOINFORMATICS
- Clinical Outcomes and Plasma Concentrations of Baloxavir Marboxil and Favipiravir in COVID-19 Patients: An Exploratory Randomized, Controlled Trial
- (2020) Yan Lou et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19
- (2020) Christoph D. Spinner et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Lopinavir–ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
- (2020) Peter W Horby et al. LANCET
- COVID-19: Current understanding of its pathophysiology, clinical presentation and treatment
- (2020) Anant Parasher POSTGRADUATE MEDICAL JOURNAL
- Characteristics and outcomes of acute respiratory distress syndrome related to COVID-19 in Belgian and French intensive care units according to antiviral strategies: the COVADIS multicentre observational study
- (2020) David Grimaldi et al. Annals of Intensive Care
- COVID-19: Antiviral Agents, Antibody Development and Traditional Chinese Medicine
- (2020) Wenyi Guan et al. VIROLOGICA SINICA
- Detailed Molecular Interactions of Favipiravir with SARS-CoV-2, SARS-CoV, MERS-CoV, and Influenza Virus Polymerases In Silico
- (2020) Mitsuru Sada et al. Microorganisms
- Efficacy and safety of lopinavir/ritonavir in the treatment of COVID-19: A systematic review
- (2020) Betsy Ann Joseph et al. Expert Review of Anti-Infective Therapy
- Role of favipiravir in the treatment of COVID-19
- (2020) Shashank Joshi et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Randomized controlled open label trial on the use of favipiravir combined with inhaled interferon beta-1b in hospitalized patients with moderate to severe COVID-19 pneumonia
- (2020) Faryal Khamis et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Repurposed Antiviral Drugs for Covid-19 — Interim WHO Solidarity Trial Results
- (2020) NEW ENGLAND JOURNAL OF MEDICINE
- Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19
- (2020) Andre C. Kalil et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and harms of remdesivir for the treatment of COVID-19: A systematic review and meta-analysis
- (2020) Alejandro Piscoya et al. PLoS One
- Antimicrobial Peptide K11 Selectively Recognizes Bacterial Biomimetic Membranes and Acts by Twisting Their Bilayers
- (2020) Francisco Ramos-Martín et al. Pharmaceuticals
- Efficacy and safety of favipiravir, an oral RNA-dependent RNA polymerase inhibitor, in mild-to-moderate COVID-19: A randomized, comparative, open-label, multicenter, phase 3 clinical trial
- (2020) Zarir F. Udwadia et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Coronaviruses — drug discovery and therapeutic options
- (2016) Alimuddin Zumla et al. NATURE REVIEWS DRUG DISCOVERY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now